Sampre Nutrition

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE375C01022
  • NSEID:
  • BSEID: 530617
INR
17.00
-0.29 (-1.68%)
BSENSE

Apr 09

BSE+NSE Vol: 1.23 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 981259,
    "name": "Sampre Nutrition",
    "stock_name": "Sampre Nutrition",
    "full_name": "Sampre Nutritions Ltd",
    "name_url": "stocks-analysis/sampre-nutrition",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.00",
    "chg": -0.29,
    "chgp": "-1.68%",
    "dir": -1,
    "prev_price": "17.29",
    "mcapval": "166.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530617,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "India SENSEX",
    "isin": "INE375C01022",
    "curr_date": "Apr 09",
    "curr_time": "",
    "bse_nse_vol": "1.23 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 09, 2026",
    "traded_date_str": "2026 04 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sampre-nutrition-981259-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sampre Nutritions Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sampre-nutritions-ltd-is-rated-strong-sell-3927324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SampreNutrition_mojoScore_3927324.png",
        "date": "2026-03-31 10:10:13",
        "description": "Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Sampre Nutritions Ltd Falls 1.22%: Death Cross and Downgrade Signal Rising Risks",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sampre-nutritions-ltd-falls-122-death-cross-and-downgrade-signal-rising-risks-3905274",
        "imagepath": "",
        "date": "2026-03-21 14:04:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Mar:</strong> Stock opens at Rs.22.11, begins week with modest gains</p>\n                    <p><strong>19 Mar:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>19 Mar:</strong> Downgrade to Strong Sell rating by MarketsMOJO</p>\n                    <p><strong>20 Mar:</strong> Week closes at Rs.21.84, down 1.22% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.22.11</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.21.84<..."
      },
      {
        "title": "Sampre Nutritions Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sampre-nutritions-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-concerns-3902390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SampreNutrition_mojoScore_3902390.png",
        "date": "2026-03-20 08:08:59",
        "description": "Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has seen its investment rating downgraded from Sell to Strong Sell as of 19 Mar 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite recent positive quarterly results and impressive stock returns over the past year."
      },
      {
        "title": "Sampre Nutritions Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sampre-nutritions-ltd-forms-death-cross-signalling-potential-bearish-trend-3901384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SampreNutrition_dealthcross_3901384.png",
        "date": "2026-03-19 18:00:30",
        "description": "Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has recently formed a Death Cross as its 50-day moving average (DMA) crossed below the 200 DMA, signalling a potential shift towards a bearish trend. This technical development, coupled with deteriorating momentum indicators and a downgrade in its Mojo Grade to Strong Sell, raises concerns about the stock's near-term outlook despite its impressive long-term performance."
      },
      {
        "title": "Sampre Nutritions Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sampre-nutritions-ltd-is-rated-sell-3886627",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SampreNutrition_mojoScore_3886627.png",
        "date": "2026-03-12 10:10:34",
        "description": "Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sampre Nutritions Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sampre-nutritions-ltd-is-rated-sell-3862084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SampreNutrition_mojoScore_3862084.png",
        "date": "2026-02-28 10:10:14",
        "description": "Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sampre Nutritions Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sampre-nutritions-ltd-is-rated-sell-3844136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SampreNutrition_mojoScore_3844136.png",
        "date": "2026-02-17 10:10:38",
        "description": "Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "When is the next results date for Sampre Nutritions Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sampre-nutritions-ltd-3836089",
        "imagepath": "",
        "date": "2026-02-12 23:16:33",
        "description": "The next results date for Sampre Nutritions Ltd is scheduled for 13 February 2026...."
      },
      {
        "title": "Sampre Nutritions Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sampre-nutritions-ltd-is-rated-sell-3824064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SampreNutrition_mojoScore_3824064.png",
        "date": "2026-02-06 10:10:50",
        "description": "Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 5516,
    "sid": "981259",
    "stock_news_url": "https://www.marketsmojo.com/news/sampre-nutritions-981259"
  },
  "announcements": [
    {
      "caption": "Rumour verification - Regulation 30(11)",
      "datetime": "18-Feb-2026",
      "details": "Submission of clarification under Regulation 30(11) of the SEBI (LODR) Regulations 2015 in respect of information circulating on certain social media platforms. No such combined / joint agreements as alleged has been entered into. Investors are advised to follow the companys filings made only on the stock exchange platforms for verifiable news.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "Publication of the standalone and consolidated unaudited financial statements of the company for the third quarter and nine-month period ended on 31 December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Third Quarter And Nine-Month Period 31 December 2025; With Appointment Of A Non-Executive Non-Independent Additio",
      "datetime": "13-Feb-2026",
      "details": "Board meeting outcome for standalone and consolidated unaudited financial results for the third quarter and nine-month period ended 31 December 2025; with appointment of a non-executive non-independent additional director.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>5:10</strong> stock split, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Sampre Nutritions Ltd Falls 1.22%: Death Cross and Downgrade Signal Rising Risks

2026-03-21 14:04:27

Key Events This Week

16 Mar: Stock opens at Rs.22.11, begins week with modest gains

19 Mar: Death Cross formation signals potential bearish trend

19 Mar: Downgrade to Strong Sell rating by MarketsMOJO

20 Mar: Week closes at Rs.21.84, down 1.22% for the week

stock-recommendationAnnouncement

Rumour verification - Regulation 30(11)

18-Feb-2026 | Source : BSE

Submission of clarification under Regulation 30(11) of the SEBI (LODR) Regulations 2015 in respect of information circulating on certain social media platforms. No such combined / joint agreements as alleged has been entered into. Investors are advised to follow the companys filings made only on the stock exchange platforms for verifiable news.

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Feb-2026 | Source : BSE

Publication of the standalone and consolidated unaudited financial statements of the company for the third quarter and nine-month period ended on 31 December 2025.

Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Third Quarter And Nine-Month Period 31 December 2025; With Appointment Of A Non-Executive Non-Independent Additio

13-Feb-2026 | Source : BSE

Board meeting outcome for standalone and consolidated unaudited financial results for the third quarter and nine-month period ended 31 December 2025; with appointment of a non-executive non-independent additional director.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Sampre Nutritions Ltd has announced 5:10 stock split, ex-date: 14 Nov 25

stock-summary
BONUS

Sampre Nutritions Ltd has announced 1:1 bonus issue, ex-date: 14 Nov 25

stock-summary
RIGHTS

No Rights history available